Published TCIMAIL newest issue No.196
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 42017-89-0 | Product Number: F1011
Fenofibric Acid
×
![]()
×
Purity: >98.0%(GC)(T)
Synonyms:
- 2-[4-(4-Chlorobenzoyl)phenoxy]-2-methylpropionic Acid
Product Documents:
| Size | Unit Price | Belgium | Japan* | Quantity |
|---|---|---|---|---|
| 1G |
33,00 €
|
1 | 8 |
|
| 5G |
112,00 €
|
1 | 23 |
|
*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).
| Product Number | F1011 |
| Purity / Analysis Method | >98.0%(GC)(T) |
| Molecular Formula / Molecular Weight | C__1__7H__1__5ClO__4 = 318.75 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Room Temperature (Recommended in a cool and dark place, <15°C) |
| CAS RN | 42017-89-0 |
| Reaxys Registry Number | 2058973 |
| PubChem Substance ID | 253661146 |
| MDL Number | MFCD00792461 |
Specifications
| Appearance | White to Almost white powder to crystal |
| Purity(GC) | min. 98.0 % |
| Purity(Neutralization titration) | min. 98.0 % |
| Melting point | 179.0 to 183.0 °C |
Properties (reference)
| Melting Point | 181 °C |
GHS
| Pictogram |
|
| Signal Word | Warning |
| Hazard Statements | H302 : Harmful if swallowed. H411 : Toxic to aquatic life with long lasting effects. |
| Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P273 : Avoid release to the environment. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P391 : Collect spillage. P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. |
Related Laws:
| EC Number | 255-626-9 |
| RTECS# | UA2453000 |
Transport Information:
| UN Number | UN3077 |
| Class | 9 |
| Packing Group | III |
| HS Number | 2918999090 |
Application
Fenofibric Acid: An Activator of peroxisome proliferator activated receptor α(PPARα)
Fenofibric acid, an active form of fenofibrate [F0674], activates peroxisome proliferator activated receptor α (PPARα) to modify fatty acid and lipid metabolite. Therefore, fenofibric acid helps reduce lowering triglycerides (TG) and high-density lipoprotein cholesterol (HDL-C) levels, and increase low-density lipoprotein cholesterol (LDL-C) level in the blood. Fenofibric acid and fenofibrate are often co-administered with a HMG-CoA reductase inhibitor (statin) to the treatment of dyslipidemia. (The product is for research purpose only.)
References
- Fenofibric Acid, an Active Form of Fenofibrate, Increases Apolipoprotein A-I-Mediated High-Density Lipoprotein Biogenesis by Enhancing Transcription of ATP-Binding Cassette Transporter A1 Gene in a Liver X Receptor-Dependent Manner
- Fenofibric acid: In combination therapy in the treatment of mixed dyslipidemia (a review)
- Determination of bezafibrate, ciprofibrate and fenofibric acid in human plasma by high-performance liquid chromatography
- Stability indicating UPLC method for simultaneous determination of atorvastatin, fenofibrate and their degradation products in tablets
PubMed Literature
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.